Subscribe To
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will report second quarter 2023 financial results on […] The post TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participatio...
Read More
Posted: Jul 26 2023, 11:00
Author Name: forextv
Views: 080844